How to Get Rid of a Yeast Infection: Treatments That Work

Most vaginal yeast infections clear up within a few days to a week using either a single oral dose of fluconazole or a short course of an over-the-counter topical antifungal like clotrimazole or miconazole. These two approaches have been compared head-to-head in multiple clinical trials and perform similarly for uncomplicated infections, with clinical cure rates in the range of 85 to 97 percent at the two-week mark. The real complexity starts when infections keep coming back, when standard drugs stop working, or when the wrong diagnosis was made in the first place.

The Two Standard Treatments

For a straightforward yeast infection, you have two well-studied options. The first is a single 150 mg oral dose of fluconazole, a prescription pill sold under the brand name Diflucan. The second is a topical azole cream or suppository, most commonly clotrimazole or miconazole, applied inside the vagina for one to seven days depending on the formulation. Many of the topical versions are available over the counter.

Trials comparing the two routes consistently find they work about equally well for a first or occasional infection. One trial found clinical cure at two weeks in about 94 percent of fluconazole-treated patients and 97 percent of those using topical clotrimazole, with no statistically significant difference between them.¹ Another trial of severe infections found comparable results at roughly 89 percent clinical cure for both.² Where fluconazole may have an edge is in sustained clearance: one study found that at a later follow-up visit, only one patient in the fluconazole group still had clinical signs of infection compared to 17 in the clotrimazole group.³

Practically, the choice often comes down to convenience and personal preference. A single pill is simpler. Topical treatments avoid systemic drug exposure and can soothe itching locally. If you have used an OTC cream before and it cleared your symptoms within a week, there is usually no reason to switch. If symptoms persist past a week or return quickly, that changes the picture entirely.

When Self-Diagnosis Goes Wrong

One of the most under-appreciated problems with yeast infection treatment is that a large fraction of people who self-diagnose are actually wrong. The classic symptoms of itching, burning, and thick white discharge overlap substantially with bacterial vaginosis and trichomoniasis, and many people have more than one cause of vaginitis at the same time. A molecular vaginitis test was found to have significantly higher sensitivity and negative predictive value than clinician assessment or standard in-clinic testing, and it was notably better at detecting infections with more than one cause.⁴ Even trained clinicians get it wrong often enough that newer molecular tests are being recommended to improve accuracy and reduce inappropriate treatment.⁵

This matters because treating bacterial vaginosis with an antifungal does nothing, and using the wrong treatment delays relief while potentially disrupting your vaginal flora further. If you have used an OTC yeast treatment and your symptoms have not resolved, or if you are not certain of the diagnosis, a proper evaluation with a culture or molecular test is worth more than another tube of cream.

What Causes Some Infections to Resist Treatment

The yeast behind most vaginal infections is Candida albicans. In its normal state it lives harmlessly on mucosal surfaces, but when conditions shift it can switch to a more invasive form that penetrates tissue and causes inflammation.⁶ Fluconazole handles C. albicans well in most people, but a meaningful percentage of infections involve non-albicans species, particularly Candida glabrata. In some regions, C. glabrata accounts for a substantial minority of cases, and it tends to be less responsive to standard azole drugs.⁷

Even among C. albicans strains, fluconazole resistance has been creeping upward. When you take fluconazole for an infection that turns out to be resistant, you get temporary symptom relief at best, followed by a return of symptoms that can feel maddening. This is why a culture or species identification test matters if a standard treatment fails. The species determines which drug will work.

Boric Acid for Resistant and Recurring Infections

Boric acid vaginal suppositories have been used for decades as a second-line treatment, and the clinical evidence supports them in specific situations. A review of case series found mycological cure rates ranging from 40 to 100 percent, with the strongest results in women whose infections were caused by non-albicans species or azole-resistant strains.⁸ In a study specifically of fluconazole-resistant C. albicans infections, vaginal boric acid achieved a mycological cure rate of about 86 percent and a clinical cure rate of roughly 74 percent, though about 14 percent of patients had a recurrence within three months.⁹

Lab research helps explain why boric acid works against resistant strains: it inhibits Candida growth at concentrations achievable inside the vagina, including fluconazole-resistant strains, and at high concentrations it is directly fungicidal.¹⁰ Side effects are generally mild, primarily vaginal burning in fewer than 10 percent of cases and watery discharge during treatment. Boric acid should never be taken orally and must be kept away from children, as it is toxic when swallowed. It is also not recommended during pregnancy.

Ibrexafungerp, the Newest Prescription Option

For years, the menu of antifungal drugs for yeast infections was essentially limited to the azole class. That changed with the FDA approval of ibrexafungerp (brand name Brexafemme), which works through a completely different mechanism. In phase 3 trials, ibrexafungerp showed higher clinical and mycological cure rates compared to placebo at both 10 and 25 days after treatment.¹¹ A meta-analysis of randomized controlled trials found ibrexafungerp to have a superior clinical cure ratio compared to fluconazole or placebo.¹²

Ibrexafungerp is particularly relevant for two groups: people with infections resistant to azoles, and people with recurrent infections who need a prevention strategy. It received FDA approval for once-monthly dosing to reduce recurrence, with about 65 percent of patients remaining symptom-free and culture-negative through six months on the monthly regimen compared to roughly 53 percent on placebo.¹¹ The drug is currently expensive and not always covered by insurance, so in practice it tends to be reserved for cases where standard options have not worked.

How to Handle Recurrent Yeast Infections

Recurrent vulvovaginal candidiasis is defined as four or more symptomatic episodes within a year, and it affects a sizable minority of women who get yeast infections. The evidence here is clear that treating each episode individually is less effective than a suppressive maintenance strategy. The best-studied approach is weekly fluconazole for six months after initial clearance of the active infection. In a landmark trial, about 91 percent of women on weekly fluconazole remained disease-free at six months, compared to 36 percent on placebo. The median time to recurrence was stretched to over 10 months in the treatment group versus just four months without it.¹³

A variation on this approach uses an individualized, gradually decreasing dose schedule rather than a fixed weekly dose for the full six months. One study using this tapering regimen found about 90 percent of women remained disease-free at six months and 77 percent at one year.¹⁴ The tapering approach may reduce total drug exposure while preserving efficacy, and it allows your provider to adjust the schedule based on how you respond.

The honest reality of maintenance therapy is that it works extremely well while you are on it, but a significant fraction of people relapse once it stops. The trial data reflect this: cure rates at the end of the maintenance period are high, but they decline over the following months. For some people, a longer or repeated course is necessary. If recurrences resume, it is worth confirming the species again, since non-albicans infections and resistant strains may have emerged during treatment.

Probiotics and Other “Natural” Approaches

Probiotics are one of the most-searched remedies for yeast infections, and the research picture is genuinely mixed. On the positive side, combining probiotics with standard azole therapy appears to improve short-term cure rates and reduce the chance of recurrence at six months.¹⁵ A separate meta-analysis similarly found that probiotics added to azole treatment reduced positive cultures and clinical symptoms compared to azole alone, and that probiotics lowered recurrence rates compared to placebo.¹⁶

Here is the catch: probiotics on their own, without an antifungal, do not appear to cure an active infection any better than placebo.¹⁶ And the benefit of combination therapy fades over the long term: at follow-up beyond one month, the addition of probiotics did not significantly improve mycological or clinical cure rates for either standard or recurrent infections.¹⁵ The upshot is that probiotics may be a reasonable add-on to antifungal treatment, especially for preventing recurrence, but they are not a substitute for antifungal drugs when you have active symptoms.

Tea tree oil is another commonly mentioned remedy. Lab studies have shown that tea tree oil components can inhibit fluconazole-resistant Candida strains at low concentrations and can lower the amount of fluconazole needed to kill the yeast.¹⁷ That said, lab results do not always translate to clinical effectiveness, and tea tree oil applied vaginally can cause irritation or allergic reactions. No large clinical trials support its use as a standalone treatment, so it remains firmly in the “interesting but unproven” category.

Other popular home remedies like garlic, coconut oil, and yogurt applied directly to the vagina have even less evidence behind them. Yogurt consumption supports the general idea of maintaining healthy lactobacilli, but inserting food products vaginally introduces unpredictable bacterial mixtures and potential irritants. If you want to try natural approaches, sticking with well-characterized probiotic supplements alongside proven antifungal treatment is a more evidence-supported path.

Risk Factors You Can Actually Modify

Some things that increase yeast infection risk are outside your control: genetics, hormonal fluctuations, and immune status all play a role. But several modifiable risk factors are well documented. These include high sugar intake, chronic moisture in the perineal area, antibiotic use, and hormonal contraceptives.¹⁸

In a study that asked women with recurrent infections to identify which lifestyle changes had helped them most, reducing sugar intake, keeping the perineal area dry, and discontinuing oral contraceptive pills were the factors that offered the most substantial improvement.¹⁹ None of these changes are guaranteed cures on their own, and nobody should feel blamed for developing a yeast infection. But for someone dealing with repeated episodes, they represent low-risk interventions worth trying alongside medical treatment.

Practical steps include wearing breathable cotton underwear, changing out of damp workout clothes or swimsuits quickly, avoiding scented products near the vulva, and discussing contraceptive alternatives with your provider if you suspect a connection. If you have diabetes, blood sugar management is particularly relevant, since elevated glucose directly fuels Candida growth.

Treating Yeast Infections During Pregnancy

Yeast infections are more common during pregnancy due to hormonal and immune changes, and treatment is both safe and recommended, but the drug choice narrows considerably. Topical azole antifungals, applied for at least seven days, are the recommended treatment during pregnancy because they are effective and available evidence does not link them to an increased risk of birth defects.²⁰

Oral fluconazole is a different story. While topical azoles have a reassuring safety profile, systemic azoles carry data suggesting a dose-related increase in the risk of fetal malformations.²¹ Systemic azole therapy is generally not recommended during pregnancy, especially not at the higher or repeated doses sometimes used for recurrent infections.²² The short version: if you are pregnant and have a yeast infection, stick with a topical cream or suppository and use it for the full seven-day course. If you need something beyond that, your provider can weigh the risks of alternative treatments on a case-by-case basis.

When to See a Provider Instead of Treating at Home

OTC treatment is reasonable if you have had a yeast infection before, recognize the symptoms, and have no complicating factors. But several situations warrant professional evaluation rather than another trip to the pharmacy:

First infection: If you have never been diagnosed with a yeast infection, the symptoms could easily be something else. Getting a proper diagnosis now saves you from a cycle of wrong treatments later.
Frequent recurrences: Four or more episodes in a year calls for a culture to identify the species and a discussion about suppressive therapy.
Failed OTC treatment: Symptoms that do not resolve after a full course of treatment suggest either a resistant strain, a non-albicans species, or a misdiagnosis.
Severe symptoms: Extensive redness, swelling, cracking of the vulvar skin, or pain that interferes with daily activities often needs prescription-strength treatment and a longer course.
Pregnancy: As noted above, drug selection matters and oral antifungals should be avoided.
Compromised immunity: People on immunosuppressive drugs, undergoing chemotherapy, or living with uncontrolled HIV face higher risks of complicated infections that require tailored treatment.

A culture or molecular vaginitis panel can identify the exact Candida species, test for drug resistance, and simultaneously check for bacterial vaginosis and trichomoniasis, which frequently coexist with yeast. This information shapes treatment in ways that guessing from symptoms alone simply cannot.

Male Partners and Penile Yeast Infections

Yeast infections are not classified as sexually transmitted infections, but Candida can be passed between sexual partners, and men can develop symptomatic genital candidiasis. Symptoms in men typically include redness, itching, and a white patchy rash on the head of the penis, sometimes with discomfort during urination or intercourse. Uncircumcised men are at higher risk because the warm, moist environment under the foreskin favors yeast growth.

Treatment for penile yeast infections is straightforward: a topical azole cream applied for one to two weeks usually clears it. Oral fluconazole is occasionally used for more stubborn cases. Routine treatment of male partners to prevent recurrence in women has not been shown to be effective in clinical trials, so unless the male partner has symptoms, treatment is generally not recommended. If you and your partner are passing infections back and forth, both being treated simultaneously and abstaining from sexual contact until symptoms resolve is a reasonable approach to discuss with your provider.

How Long Treatment Actually Takes

The timeline for symptom relief varies by treatment type and severity. With a single dose of oral fluconazole, most people notice improvement within one to two days, but full resolution can take up to a week. OTC topical treatments typically provide some itch relief within a day or two, with the infection clearing over the course of the treatment period, which ranges from one to seven days depending on the product strength. Severe infections or those caused by resistant species may take longer and require extended or repeated treatment courses.

A common mistake is stopping topical treatment early because symptoms have improved. Even if you feel better after two or three days, completing the full course reduces the chance that surviving yeast will bounce back. With fluconazole, the single dose stays active in vaginal tissue for several days, so there is no course to cut short, but a second dose a few days later is sometimes prescribed for more severe episodes. During treatment, avoiding sex or using a non-latex barrier can help prevent irritation and reduce the small chance of transmitting yeast to a partner.

1
PubMed. Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis
2
PubMed. The efficacy and safety of clotrimazole vaginal tablet vs. oral fluconazole in treating severe vulvovaginal candidiasis
3
PubMed. Oral fluconazole 150 mg single dose versus intra-vaginal clotrimazole treatment of acute vulvovaginal candidiasis
4
PubMed Central. Diagnostic Performance of a Molecular Test versus Clinician Assessment of Vaginitis
5
PubMed Central. Improving the Diagnosis of Vulvovaginitis: Perspectives to Align Practice, Guidelines, and Awareness
6
PubMed Central. Candida albicans: the current status regarding vaginal infections – Section: Pathogenesis of Candida albicans
7
MDPI. Fluconazole-Resistant Vulvovaginal Candidosis: An Update on Current Management
8
PubMed. Boric acid for recurrent vulvovaginal candidiasis: the clinical evidence
9
PubMed. Fluconazole-Resistant Candida albicans Vaginal Infections at a Referral Center and Treated With Boric Acid
10
Journal of Antimicrobial Chemotherapy. Antifungal mechanisms supporting boric acid therapy of Candida vaginitis
11
PubMed Central. Ibrexafungerp for the Treatment of Vulvovaginal Candidiasis: Design, Development and Place in Therapy
12
Heliyon. Efficacy and safety of ibrexafungerp in the treatment of vulvovaginal candidiasis: A meta-analysis of randomized controlled trials
13
PubMed. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis
14
American Journal of Obstetrics & Gynecology. Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis
15
American Journal of Obstetrics and Gynecology. Efficacy and safety of probiotics in the treatment of vulvovaginal candidiasis and recurrent vulvovaginal candidiasis: a systematic review and meta-analysis
16
PubMed Central. The Role of Probiotics in the Treatment of Vulvovaginal Candidiasis: A Systematic Review and Meta-Analysis
17
PubMed Central. The influence of tea tree oil (Melaleuca alternifolia) on fluconazole activity against fluconazole-resistant Candida albicans strains
18
PubMed Central. The Interplay Between Sugar and Yeast Infections: Do Diabetics Have a Greater Predisposition to Develop Oral and Vulvovaginal Candidiasis?
19
PubMed. Self-elimination of risk factors for recurrent vaginal candidosis
20
PubMed Central. Vaginal yeast infections during pregnancy
21
PubMed. Antifungal drugs in pregnancy: a review
22
PubMed. Use of antifungal drugs in pregnancy: a focus on safety